LKT Labs

Biochemicals for Life Science Research

Flufenamic Acid

Flufenamic Acid

Product ID F4483
Cas No. 530-78-9
Purity ≥97%
Product Unit SizeCostQuantityStock
10 g $30.00 In stock
50 g $74.90 In stock
Bulk Quote

Quicklinks

Description

Flufenamic acid is a COX-inhibiting non-steroidal anti-inflammatory drug (NSAID) that exhibits neuromodulatory, anti-inflammatory, antipyretic, analgesic, and antiepileptic/anticonvulsant activities. Flufenamic inhibits voltage-gated Na+ channels, transient receptor potential canonical 3 (TRPC3) channels, and transient receptor potential melastatin-like 2 (TRPM2) channels and potentiates TREK1 (KCNK2) channel activity. In vitro, flufenamic acid decreases glutamatergic excitatory activity and neuronal excitability.

Product Info

Cas No.

530-78-9
Purity

≥97%
Formula

C14H10F3NO2
Formula Wt.

281.23
Chemical Name

2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid

IUPAC Name

2-[3-(trifluoromethyl)anilino]benzoic acid
Synonym

Achless, Ansatin, Arlef, Fullsafe, Parlef, Sastridex, Tecramine
Melting Point

125°C

Solubility

Soluble in 4 parts of ethanol. Soluble in DMSO to 100 mM and in ethanol to 100 mM
Appearance

White to pale yellow powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

F4483 MSDS PDF
Info Sheet

F4483 Info Sheet PDF
Brochures

TRP Channel Modulator Flyer

References

Xie YF, Zhou F. TRPC3 channel mediates excitation of striatal cholinergic interneurons. Neurol Sci. 2014 May 21. [Epub ahead of print]. PMID: 24844791.

Veale EL, Al-Moubarak E, Bajaria N, et al. Influence of the N terminus on the biophysical properties and pharmacology of TREK1 potassium channels. Mol Pharmacol. 2014 May;85(5):671-81. PMID: 24509840.

Nazıroğlu M, Özgül C, Çelik Ö, et al. Aminoethoxydiphenyl borate and flufenamic acid inhibit Ca2+ influx through TRPM2 channels in rat dorsal root ganglion neurons activated by ADP-ribose and rotenone. J Membr Biol. 2011 May;241(2):69-75. PMID: 21509529.

Yau HJ, Baranauskas G, Martina M. Flufenamic acid decreases neuronal excitability through modulation of voltage-gated sodium channel gating. J Physiol. 2010 Oct 15;588(Pt 20):3869-82. PMID: 20724367.

Fernández M, Lao-Peregrín C, Martín ED. Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability. Epilepsia. 2010 Mar;51(3):384-90. PMID: 19732136.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A0812

    Ac-D-E

    Mast cell stabilizer.
    ≥95%
  • V7200

    VS-5584

    PI3K inhibitor.
    ≥98%
  • O610292

    Ophiobolin B

    Ophiobolin B is a naturally occurring sesteterpeno...
    ≥98%
  • N5778

    Notoginsenoside R1

    Triterpene saponin found in species of Panax.
    ≥98%
  • R0212

    Radicicol

    Benzoquinone ansamycin; topoisomerase VI-B, HSP90,...
    ≥96%
  • A9817

    Azelaic Acid

    Dicarboxylic acid found in Arabidopsis; PPARγ ago...
    ≥98%
  • E4416

    Eledoisin

    Peptide, substance P analog; NK agonist.
    ≥95%
  • G2368

    GFR

    Peptide hormone found in crustaceans.
    ≥95%
  • C0048

    Cambinol

    SIRT inhibitor.
    ≥98%
  • M0040

    M40

    Peptide; galanin antagonist.
    ≥95%
  • D0244

    Dalcetrapib

    Cholesterol ester transfer protein inhibitor.
    ≥98%
  • H0169

    Harringtonine

    Cephalotaxine alkaloid originally found in Cephalo...
    ≥97%
  • E6256

    Epothilone A

    Microtubule depolymerization inhibitor.
    ≥95%
  • A5277

    Angiotensin II, human

    Endogenous peptide, involved in vasoconstriction, ...
    ≥95%
  • I0010

    5-(9-Isopropyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine

    Intermediate in the synthesis of purine analogs an...
    ≥98%
  • R2788

    RGW-611

    Morpholine derivative.
    ≥98%
  • E5200

    Enalaprilat Dihydrate

    Enalapril metabolite; ACE inhibitor.
    ≥98%
  • B5609

    Boc-GRR-AMC

    Peptide, protease substrate.
    ≥98%
  • N1993

    Neurotensin (9-13)

    Endogenous neuropeptide involved in hormone releas...
    ≥95%
  • P3600

    PJ34 Hydrochloride

    PARP inhibitor; potential Pim1 inhibitor.
    ≥95%